Correction to: Scientific Reports https://doi.org/10.1038/s41598-024-58499-5, published online 01 April 2024

The original version of this Article contained errors in Figure 2.

Due to an error during figure assembly, the image for Calcein-AM/ PI staining assay’ in 2 μM Tenovin-3group in Figure 2B was a duplication of the image for 4 μM Tenovin-3group in Figure 1F.

In addition, in Figure 2E, two GAPDH blots were given instead of a single GAPDH loading control.

The original Figure 2 and accompanying legend appears below.

Fig. 2
Fig. 2
Full size image

Tenovin-3 induces PC9 cells apoptosis. (A,B) The PC9 cells were co-treated with tenovin-3, apoptosis inhibitor Z-VAD-FMK or ferroptosis inhibitor Fer-1, and the cell viability was detected by CCK-8 assay (A) and Calcein-AM/ PI staining assay (B). (C,D) Tenovin-3 induced PC9 cells apoptosis indicated by flow cytometer assay. PC9 cells were exposure to various concentrations of tenovin-3 for 48 h, and then Annexin V/PI assay was used to detect apoptosis rate. The representative images and statistical data were displayed in (C) and (D). (E–F) The effect of tenovin-3 on the expression of apoptosis related protein detected by Western blotting. PC9 cells were treated with various concentrations of tenovin-3, and the cells were collected and subjected for Western blotting. GAPDH was set as a loading control. The representative blots and statistical data were presented in (C) and (D). The blots were cut and then incubated with antibodies. The uncropped version of the western blots is displayed in Supplementary Fig. 8. The data are presented as mean ± SD, n = 3. *P < 0.05, **P < 0.01, ***P < 0.001 compared with the control group.

The original Article has been corrected.